{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:03:38Z","timestamp":1760522618236},"reference-count":20,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.vaccine.2008.02.008","type":"journal-article","created":{"date-parts":[[2008,2,25]],"date-time":"2008-02-25T16:22:41Z","timestamp":1203956561000},"page":"2034-2040","source":"Crossref","is-referenced-by-count":19,"title":["Economics of polio vaccination in the post-eradication era: Should OPV-using countries adopt IPV?"],"prefix":"10.1016","volume":"26","author":[{"given":"M. Mahmud","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.02.008_bib1","unstructured":"World Health Organization, Polio case count, Global summary, from website http:\/\/www.who.int\/immunization_monitoring\/en\/diseases\/poliomyelitis\/case_count.cfm."},{"key":"10.1016\/j.vaccine.2008.02.008_bib2","unstructured":"World Health Organization, Resurgence of wild poliovirus type 1 transmission and effect of importation into polio-free countries, 2002\u20132005. Wkly Epidemiol Rec 2006;81(7):63\u20138."},{"issue":"1","key":"10.1016\/j.vaccine.2008.02.008_bib3","first-page":"16","article-title":"Circulating vaccine-derived polioviruses: current state of knowledge","volume":"82","author":"Kew","year":"2004","journal-title":"Bull World Health Organ"},{"issue":"4","key":"10.1016\/j.vaccine.2008.02.008_bib4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/aje\/kwi206","article-title":"A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future","volume":"162","author":"Duintjer Tebbens","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2008.02.008_bib5","unstructured":"World Health Organization. Global Polio Eradication Initiative Strategic Plan 2004\u20132008; 2003. Available at http:\/\/www.polioeradication.org\/content\/publications\/2004stratplan.pdf."},{"issue":"1","key":"10.1016\/j.vaccine.2008.02.008_bib6","first-page":"31","article-title":"The role of routine polio immunization in the post-certification era","volume":"82","author":"Sutter","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2008.02.008_bib7","unstructured":"World Health Organization. Cessation of routine oral polio vaccine (OPV) use after global polio eradication: framework for national policy makers in OPV-using countries. Geneva; 2005 (WHO\/POLIO\/05.02)."},{"key":"10.1016\/j.vaccine.2008.02.008_bib8","unstructured":"Government of India, India Expert Advisory Group (IEAG), 14th IEAG Presentation. IEAG Findings, Delhi, India, December 5\u20136, 2005."},{"key":"10.1016\/j.vaccine.2008.02.008_bib9","unstructured":"World Health Organization. Global burden of disease 2000, U013 Poliomyelitis, http:\/\/www.who.int\/."},{"issue":"1","key":"10.1016\/j.vaccine.2008.02.008_bib10","first-page":"35","article-title":"Global eradication of poliomyelitis: benefit-cost analysis","volume":"74","author":"Bart","year":"1996","journal-title":"Bull World Health Organ"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2008.02.008_bib11","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0264-410X(02)00584-4","article-title":"Costs and benefits of polio eradication: a long-run global perspective","volume":"21","author":"Khan","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.02.008_bib12","first-page":"9","article-title":"Cost analysis of post-polio certification immunization policies","volume":"82","author":"Sangrujee","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2008.02.008_bib13","series-title":"OPV and IPV: past and future choice of vaccine in the global polio eradication program","author":"Liu","year":"2002"},{"key":"10.1016\/j.vaccine.2008.02.008_bib14","unstructured":"Khan MM, Yoder RA. Expanded Program on immunization in Bangladesh: cost, cost-effectiveness, and financing estimates. Technical Report number 24. Bethesda, MD: The Partners in Health Reform Project, Abt Associates Inc.; September 1998."},{"key":"10.1016\/j.vaccine.2008.02.008_bib15","unstructured":"Kaddar M, Levin A, Dougherty L, Maceira D. Costs and financing of immunization programs: findings of four case studies. Special initiatives report no. 26. Bethesda, MD: The Partners in Health Reform Project, Abt Associates Inc.; May 2000."},{"issue":"4","key":"10.1016\/j.vaccine.2008.02.008_bib16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0277-9536(94)90095-7","article-title":"Immunization programs and their costs","volume":"39","author":"Brenzel","year":"1994","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.vaccine.2008.02.008_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/(SICI)1099-1751(199801\/03)13:1<5::AID-HPM497>3.0.CO;2-8","article-title":"Costs of polio immunization days in China: implications for mass immunization campaign strategies","volume":"13","author":"Jian","year":"1998","journal-title":"Int J Health Plann Mgmt"},{"key":"10.1016\/j.vaccine.2008.02.008_bib18","unstructured":"Kaddar M, Mookherji S, DeRoeck D, Antona D. Case study on the costs and financing of immunization services in Morocco. Special initiatives report number 18. Bethesda, MD: The Partners in Health Reform Project, Abt Associates Inc.; May 2000."},{"key":"10.1016\/j.vaccine.2008.02.008_bib19","series-title":"Health Economics: Latin American Perspectives","article-title":"Is polio eradication in the Americas economically justified?","author":"Musgrove","year":"1989"},{"issue":"4","key":"10.1016\/j.vaccine.2008.02.008_bib20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1586\/14760584.1.4.433","article-title":"Emerging issues in vaccine economics: perspectives from the USA","volume":"1","author":"Lieu","year":"2002","journal-title":"Exp Rev Vac"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08001369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08001369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T13:24:17Z","timestamp":1546262657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08001369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":20,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0264410X08001369"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.02.008","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}